Difference between revisions of "Team:MIT/Mammalian synthetic biology kit"
| Line 13: | Line 13: | ||
<a href="https://2016.igem.org/Team:MIT/pdestmcherry"><img src="https://2016.igem.org/File:T--MIT--pdestmcherryplasmid.svg" style="width:225px;height:225px;"></a> | <a href="https://2016.igem.org/Team:MIT/pdestmcherry"><img src="https://2016.igem.org/File:T--MIT--pdestmcherryplasmid.svg" style="width:225px;height:225px;"></a> | ||
| + | |||
| + | <p>these will be changed to the various pENTRs that can we include in said kit </p> | ||
<br> | <br> | ||
Revision as of 23:37, 7 October 2016
With the development of efficacious gene editing tools and improved practices, mammalian synthetic biology grows more prevalent. While our project is one example of how synthetic biology can be used to diagnose diseases, we hope that more people are able to build off our work, and the work of others to apply synthetic biology to mammalian cells..
Hoping to see what amazing work can come from future teams and scientists, we have put together a toolbox of parts to make it easier to start mammalian work.
This includes *PUT LINKS HERE FOR EACH PART (are they getting their own pages or nah?*
these will be changed to the various pENTRs that can we include in said kit
Note
You must fill out this page in order to be considered for all awards for Human Practices:
- Human Practices silver medal criterion
- Human Practices gold medal criterion
- Best Integrated Human Practices award
- Best Education and Public Engagement award
Some Human Practices topic areas
- Philosophy
- Public Engagement / Dialogue
- Education
- Product Design
- Scale-Up and Deployment Issues
- Environmental Impact
- Ethics
- Safety
- Security
- Public Policy
- Law and Regulation
- Risk Assessment
What should we write about on this page?
On this page, you should write about the Human Practices topics you considered in your project, and document any special activities you did (such as visiting experts, talking to lawmakers, or doing public engagement).
